In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Drug treatment in hypertension - New insights
Session

Event : ESC Congress 2019

Topic : Hypertension: Pharmacotherapy

  • Session type : Advances in Science
  • Date : 31 August 2019
  • Time : 11:00 - 12:30

4 presentations in this session

State of the Art - Drug treatment in hypertension: unmet needs

Event : ESC Congress 2019

  • Session : Drug treatment in hypertension - New insights
  • Speaker : B Williams (London,GB)

Can anti-hypertensive thiazide diuretics also reduce fragility fracture risk?

Event : ESC Congress 2019

  • Session : Drug treatment in hypertension - New insights
  • Speaker : J Sousa (Coimbra,PT)

Efficacy and safety of various doses of the new dual endothelin receptor antagonist aprocitentan in the treatment of hypertension

Event : ESC Congress 2019

  • Session : Drug treatment in hypertension - New insights
  • Speaker : P Danaietash (Allschwil,CH)

New targets for blood pressure lowering drugs

Event : ESC Congress 2019

  • Session : Drug treatment in hypertension - New insights
  • Speaker : G Parati (Milano,IT)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are